Global Opioids Market Growth 2020-2025

Global Opioids Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioids Consumption 2015-2025
2.1.2 Opioids Consumption CAGR by Region
2.2 Opioids Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.2.5 Other
2.3 Opioids Consumption by Type
2.3.1 Global Opioids Consumption Market Share by Type (2015-2020)
2.3.2 Global Opioids Revenue and Market Share by Type (2015-2020)
2.3.3 Global Opioids Sale Price by Type (2015-2020)
2.4 Opioids Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Cough Suppression
2.4.4 Diarrhea Suppression
2.4.5 Deaddiction
2.4.6 Others
2.5 Opioids Consumption by Application
2.5.1 Global Opioids Consumption Market Share by Type (2015-2020)
2.5.2 Global Opioids Value and Market Share by Type (2015-2020)
2.5.3 Global Opioids Sale Price by Type (2015-2020)

3 Global Opioids by Company
3.1 Global Opioids Sales Market Share by Company
3.1.1 Global Opioids Sales by Company (2018-2020)
3.1.2 Global Opioids Sales Market Share by Company (2018-2020)
3.2 Global Opioids Revenue Market Share by Company
3.2.1 Global Opioids Revenue by Company (2018-2020)
3.2.2 Global Opioids Revenue Market Share by Company (2018-2020)
3.3 Global Opioids Sale Price by Company
3.4 Global Opioids Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Opioids Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Opioids Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Opioids by Regions
4.1 Opioids by Regions
4.2 Americas Opioids Consumption Growth
4.3 APAC Opioids Consumption Growth
4.4 Europe Opioids Consumption Growth
4.5 Middle East & Africa Opioids Consumption Growth

5 Americas
5.1 Americas Opioids Consumption by Countries
5.1.1 Americas Opioids Consumption by Countries (2015-2020)
5.1.2 Americas Opioids Value by Countries (2015-2020)
5.2 Americas Opioids Consumption by Type
5.3 Americas Opioids Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Opioids Consumption by Regions
6.1.1 APAC Opioids Consumption by Regions (2015-2020)
6.1.2 APAC Opioids Value by Regions (2015-2020)
6.2 APAC Opioids Consumption by Type
6.3 APAC Opioids Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Opioids by Countries
7.1.1 Europe Opioids Consumption by Countries (2015-2020)
7.1.2 Europe Opioids Value by Countries (2015-2020)
7.2 Europe Opioids Consumption by Type
7.3 Europe Opioids Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Opioids by Countries
8.1.1 Middle East & Africa Opioids Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Opioids Value by Countries (2015-2020)
8.2 Middle East & Africa Opioids Consumption by Type
8.3 Middle East & Africa Opioids Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opioids Distributors
10.3 Opioids Customer

11 Global Opioids Market Forecast
11.1 Global Opioids Consumption Forecast (2021-2025)
11.2 Global Opioids Forecast by Regions
11.2.1 Global Opioids Forecast by Regions (2021-2025)
11.2.2 Global Opioids Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Opioids Forecast by Type
11.8 Global Opioids Forecast by Application

12 Key Players Analysis
12.1 Teva
12.1.1 Company Information
12.1.2 Opioids Product Offered
12.1.3 Teva Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Teva Latest Developments
12.2 Mylan
12.2.1 Company Information
12.2.2 Opioids Product Offered
12.2.3 Mylan Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Mylan Latest Developments
12.3 Purdue Pharma
12.3.1 Company Information
12.3.2 Opioids Product Offered
12.3.3 Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Purdue Pharma Latest Developments
12.4 Amneal Pharma
12.4.1 Company Information
12.4.2 Opioids Product Offered
12.4.3 Amneal Pharma Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Amneal Pharma Latest Developments
12.5 Collegium
12.5.1 Company Information
12.5.2 Opioids Product Offered
12.5.3 Collegium Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Collegium Latest Developments
12.6 Mallinckrodt
12.6.1 Company Information
12.6.2 Opioids Product Offered
12.6.3 Mallinckrodt Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mallinckrodt Latest Developments
12.7 Pfizer
12.7.1 Company Information
12.7.2 Opioids Product Offered
12.7.3 Pfizer Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 J&J
12.8.1 Company Information
12.8.2 Opioids Product Offered
12.8.3 J&J Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 J&J Latest Developments
12.9 INSYS
12.9.1 Company Information
12.9.2 Opioids Product Offered
12.9.3 INSYS Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 INSYS Latest Developments
12.10 Endo
12.10.1 Company Information
12.10.2 Opioids Product Offered
12.10.3 Endo Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Endo Latest Developments
12.11 Hikma
12.11.1 Company Information
12.11.2 Opioids Product Offered
12.11.3 Hikma Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Hikma Latest Developments
12.12 Egalet
12.12.1 Company Information
12.12.2 Opioids Product Offered
12.12.3 Egalet Opioids Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Egalet Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Opioids Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oxycodone
Table 5. Major Players of Hydromorphone
Table 6. Major Players of Codeine
Table 7. Major Players of Fentanyl
Table 8. Major Players of Other
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Opioids Consumption Market Share by Type (2015-2020)
Table 11. Global Opioids Revenue by Type (2015-2020) ($ million)
Table 12. Global Opioids Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Opioids Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Opioids Consumption Market Share by Application (2015-2020)
Table 16. Global Opioids Value by Application (2015-2020)
Table 17. Global Opioids Value Market Share by Application (2015-2020)
Table 18. Global Opioids Sale Price by Application (2015-2020)
Table 19. Global Opioids Sales by Company (2017-2019) (MT)
Table 20. Global Opioids Sales Market Share by Company (2017-2019)
Table 21. Global Opioids Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Opioids Revenue Market Share by Company (2017-2019)
Table 23. Global Opioids Sale Price by Company (2017-2019)
Table 24. Global Opioids Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Opioids Products Offered
Table 26. Opioids Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Opioids Consumption by Regions 2015-2020 (MT)
Table 28. Global Opioids Consumption Market Share by Regions 2015-2020
Table 29. Global Opioids Value by Regions 2015-2020 ($ Millions)
Table 30. Global Opioids Value Market Share by Regions 2015-2020
Table 31. Americas Opioids Consumption by Countries (2015-2020) (MT)
Table 32. Americas Opioids Consumption Market Share by Countries (2015-2020)
Table 33. Americas Opioids Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Opioids Value Market Share by Countries (2015-2020)
Table 35. Americas Opioids Consumption by Type (2015-2020) (MT)
Table 36. Americas Opioids Consumption Market Share by Type (2015-2020)
Table 37. Americas Opioids Consumption by Application (2015-2020) (MT)
Table 38. Americas Opioids Consumption Market Share by Application (2015-2020)
Table 39. APAC Opioids Consumption by Regions (2015-2020) (MT)
Table 40. APAC Opioids Consumption Market Share by Regions (2015-2020)
Table 41. APAC Opioids Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Opioids Value Market Share by Regions (2015-2020)
Table 43. APAC Opioids Consumption by Type (2015-2020) (MT)
Table 44. APAC Opioids Consumption Market Share by Type (2015-2020)
Table 45. APAC Opioids Consumption by Application (2015-2020) (MT)
Table 46. APAC Opioids Consumption Market Share by Application (2015-2020)
Table 47. Europe Opioids Consumption by Countries (2015-2020) (MT)
Table 48. Europe Opioids Consumption Market Share by Countries (2015-2020)
Table 49. Europe Opioids Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Opioids Value Market Share by Countries (2015-2020)
Table 51. Europe Opioids Consumption by Type (2015-2020) (MT)
Table 52. Europe Opioids Consumption Market Share by Type (2015-2020)
Table 53. Europe Opioids Consumption by Application (2015-2020) (MT)
Table 54. Europe Opioids Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Opioids Consumption by Countries (2015-2020) (MT)
Table 56. Middle East & Africa Opioids Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Opioids Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Opioids Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Opioids Consumption by Type (2015-2020) (MT)
Table 60. Middle East & Africa Opioids Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Opioids Consumption by Application (2015-2020) (MT)
Table 62. Middle East & Africa Opioids Consumption Market Share by Application (2015-2020)
Table 63. Opioids Distributors List
Table 64. Opioids Customer List
Table 65. Global Opioids Consumption Forecast by Countries (2021-2025) (MT)
Table 66. Global Opioids Consumption Market Forecast by Regions
Table 67. Global Opioids Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Opioids Value Market Share Forecast by Regions
Table 69. Global Opioids Consumption Forecast by Type (2021-2025) (MT)
Table 70. Global Opioids Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Opioids Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Opioids Value Market Share Forecast by Type (2021-2025)
Table 73. Global Opioids Consumption Forecast by Application (2021-2025) (MT)
Table 74. Global Opioids Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Opioids Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Opioids Value Market Share Forecast by Application (2021-2025)
Table 77. Teva Product Offered
Table 78. Teva Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 79. Teva Main Business
Table 80. Teva Latest Developments
Table 81. Teva Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 82. Mylan Product Offered
Table 83. Mylan Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Mylan Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 87. Purdue Pharma Product Offered
Table 88. Purdue Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 89. Purdue Pharma Main Business
Table 90. Purdue Pharma Latest Developments
Table 91. Purdue Pharma Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 92. Amneal Pharma Product Offered
Table 93. Amneal Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 94. Amneal Pharma Main Business
Table 95. Amneal Pharma Latest Developments
Table 96. Amneal Pharma Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 97. Collegium Product Offered
Table 98. Collegium Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 99. Collegium Main Business
Table 100. Collegium Latest Developments
Table 101. Collegium Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 102. Mallinckrodt Product Offered
Table 103. Mallinckrodt Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 104. Mallinckrodt Main Business
Table 105. Mallinckrodt Latest Developments
Table 106. Mallinckrodt Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Product Offered
Table 108. Pfizer Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Main Business
Table 110. Pfizer Latest Developments
Table 111. Pfizer Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 112. J&J Product Offered
Table 113. J&J Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 114. J&J Main Business
Table 115. J&J Latest Developments
Table 116. J&J Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 117. INSYS Product Offered
Table 118. INSYS Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 119. INSYS Main Business
Table 120. INSYS Latest Developments
Table 121. INSYS Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 122. Endo Product Offered
Table 123. Endo Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 124. Endo Main Business
Table 125. Endo Latest Developments
Table 126. Endo Basic Information, Company Total Revenue (in $ million), Opioids Manufacturing Base, Sales Area and Its Competitors
Table 127. Hikma Product Offered
Table 128. Hikma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 129. Hikma Main Business
Table 130. Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Latest Developments
Table 132. Egalet Product Offered
Table 133. Egalet Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 134. Egalet Main Business
Table 135. Egalet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Egalet Latest Developments
List of Figures
Figure 1. Picture of Opioids
Figure 2. Opioids Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Opioids Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Opioids Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oxycodone
Figure 7. Product Picture of Hydromorphone
Figure 8. Product Picture of Codeine
Figure 9. Product Picture of Fentanyl
Figure 10. Product Picture of Other
Figure 11. Global Opioids Consumption Market Share by Type (2015-2020)
Figure 12. Global Opioids Value Market Share by Type (2015-2020)
Figure 13. Opioids Consumed in Pain Relief
Figure 14. Global Opioids Market: Pain Relief (2015-2020) (MT)
Figure 15. Global Opioids Market: Pain Relief (2015-2020) ($ Millions)
Figure 16. Opioids Consumed in Anesthesia
Figure 17. Global Opioids Market: Anesthesia (2015-2020) (MT)
Figure 18. Global Opioids Market: Anesthesia (2015-2020) ($ Millions)
Figure 19. Opioids Consumed in Cough Suppression
Figure 20. Global Opioids Market: Cough Suppression (2015-2020) (MT)
Figure 21. Global Opioids Market: Cough Suppression (2015-2020) ($ Millions)
Figure 22. Opioids Consumed in Diarrhea Suppression
Figure 23. Global Opioids Market: Diarrhea Suppression (2015-2020) (MT)
Figure 24. Global Opioids Market: Diarrhea Suppression (2015-2020) ($ Millions)
Figure 25. Opioids Consumed in Deaddiction
Figure 26. Global Opioids Market: Deaddiction (2015-2020) (MT)
Figure 27. Global Opioids Market: Deaddiction (2015-2020) ($ Millions)
Figure 28. Opioids Consumed in Others
Figure 29. Global Opioids Consumption Market Share by Application (2015-2020)
Figure 30. Global Opioids Value Market Share by Application (2015-2020)
Figure 31. Global Opioids Sales Market Share by Company in 2017
Figure 32. Global Opioids Sales Market Share by Company in 2019
Figure 33. Global Opioids Revenue Market Share by Company in 2017
Figure 34. Global Opioids Revenue Market Share by Company in 2019
Figure 35. Global Opioids Sale Price by Company in 2019
Figure 36. Global Opioids Consumption Market Share by Regions 2015-2020
Figure 37. Global Opioids Value Market Share by Regions 2015-2020
Figure 38. Americas Opioids Consumption 2015-2020 (MT)
Figure 39. Americas Opioids Value 2015-2020 ($ Millions)
Figure 40. APAC Opioids Consumption 2015-2020 (MT)
Figure 41. APAC Opioids Value 2015-2020 ($ Millions)
Figure 42. Europe Opioids Consumption 2015-2020 (MT)
Figure 43. Europe Opioids Value 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Opioids Consumption 2015-2020 (MT)
Figure 45. Middle East & Africa Opioids Value 2015-2020 ($ Millions)
Figure 46. Americas Opioids Consumption Market Share by Countries in 2019
Figure 47. Americas Opioids Value Market Share by Countries in 2019
Figure 48. Americas Opioids Consumption Market Share by Type in 2019
Figure 49. Americas Opioids Consumption Market Share by Application in 2019
Figure 50. United States Opioids Consumption Growth 2015-2020 (MT)
Figure 51. United States Opioids Value Growth 2015-2020 ($ Millions)
Figure 52. Canada Opioids Consumption Growth 2015-2020 (MT)
Figure 53. Canada Opioids Value Growth 2015-2020 ($ Millions)
Figure 54. Mexico Opioids Consumption Growth 2015-2020 (MT)
Figure 55. Mexico Opioids Value Growth 2015-2020 ($ Millions)
Figure 56. APAC Opioids Consumption Market Share by Countries in 2019
Figure 57. APAC Opioids Value Market Share by Regions in 2019
Figure 58. APAC Opioids Consumption Market Share by Type in 2019
Figure 59. APAC Opioids Consumption Market Share by Application in 2019
Figure 60. China Opioids Consumption Growth 2015-2020 (MT)
Figure 61. China Opioids Value Growth 2015-2020 ($ Millions)
Figure 62. Japan Opioids Consumption Growth 2015-2020 (MT)
Figure 63. Japan Opioids Value Growth 2015-2020 ($ Millions)
Figure 64. Korea Opioids Consumption Growth 2015-2020 (MT)
Figure 65. Korea Opioids Value Growth 2015-2020 ($ Millions)
Figure 66. Southeast Asia Opioids Consumption Growth 2015-2020 (MT)
Figure 67. Southeast Asia Opioids Value Growth 2015-2020 ($ Millions)
Figure 68. India Opioids Consumption Growth 2015-2020 (MT)
Figure 69. India Opioids Value Growth 2015-2020 ($ Millions)
Figure 70. Australia Opioids Consumption Growth 2015-2020 (MT)
Figure 71. Australia Opioids Value Growth 2015-2020 ($ Millions)
Figure 72. Europe Opioids Consumption Market Share by Countries in 2019
Figure 73. Europe Opioids Value Market Share by Countries in 2019
Figure 74. Europe Opioids Consumption Market Share by Type in 2019
Figure 75. Europe Opioids Consumption Market Share by Application in 2019
Figure 76. Germany Opioids Consumption Growth 2015-2020 (MT)
Figure 77. Germany Opioids Value Growth 2015-2020 ($ Millions)
Figure 78. France Opioids Consumption Growth 2015-2020 (MT)
Figure 79. France Opioids Value Growth 2015-2020 ($ Millions)
Figure 80. UK Opioids Consumption Growth 2015-2020 (MT)
Figure 81. UK Opioids Value Growth 2015-2020 ($ Millions)
Figure 82. Italy Opioids Consumption Growth 2015-2020 (MT)
Figure 83. Italy Opioids Value Growth 2015-2020 ($ Millions)
Figure 84. Russia Opioids Consumption Growth 2015-2020 (MT)
Figure 85. Russia Opioids Value Growth 2015-2020 ($ Millions)
Figure 86. Middle East & Africa Opioids Consumption Market Share by Countries in 2019
Figure 87. Middle East & Africa Opioids Value Market Share by Countries in 2019
Figure 88. Middle East & Africa Opioids Consumption Market Share by Type in 2019
Figure 89. Middle East & Africa Opioids Consumption Market Share by Application in 2019
Figure 90. Egypt Opioids Consumption Growth 2015-2020 (MT)
Figure 91. Egypt Opioids Value Growth 2015-2020 ($ Millions)
Figure 92. South Africa Opioids Consumption Growth 2015-2020 (MT)
Figure 93. South Africa Opioids Value Growth 2015-2020 ($ Millions)
Figure 94. Israel Opioids Consumption Growth 2015-2020 (MT)
Figure 95. Israel Opioids Value Growth 2015-2020 ($ Millions)
Figure 96. Turkey Opioids Consumption Growth 2015-2020 (MT)
Figure 97. Turkey Opioids Value Growth 2015-2020 ($ Millions)
Figure 98. GCC Countries Opioids Consumption Growth 2015-2020 (MT)
Figure 99. GCC Countries Opioids Value Growth 2015-2020 ($ Millions)
Figure 100. Global Opioids Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 101. Global Opioids Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 102. Americas Opioids Consumption 2021-2025 (MT)
Figure 103. Americas Opioids Value 2021-2025 ($ Millions)
Figure 104. APAC Opioids Consumption 2021-2025 (MT)
Figure 105. APAC Opioids Value 2021-2025 ($ Millions)
Figure 106. Europe Opioids Consumption 2021-2025 (MT)
Figure 107. Europe Opioids Value 2021-2025 ($ Millions)
Figure 108. Middle East & Africa Opioids Consumption 2021-2025 (MT)
Figure 109. Middle East & Africa Opioids Value 2021-2025 ($ Millions)
Figure 110. United States Opioids Consumption 2021-2025 (MT)
Figure 111. United States Opioids Value 2021-2025 ($ Millions)
Figure 112. Canada Opioids Consumption 2021-2025 (MT)
Figure 113. Canada Opioids Value 2021-2025 ($ Millions)
Figure 114. Mexico Opioids Consumption 2021-2025 (MT)
Figure 115. Mexico Opioids Value 2021-2025 ($ Millions)
Figure 116. Brazil Opioids Consumption 2021-2025 (MT)
Figure 117. Brazil Opioids Value 2021-2025 ($ Millions)
Figure 118. China Opioids Consumption 2021-2025 (MT)
Figure 119. China Opioids Value 2021-2025 ($ Millions)
Figure 120. Japan Opioids Consumption 2021-2025 (MT)
Figure 121. Japan Opioids Value 2021-2025 ($ Millions)
Figure 122. Korea Opioids Consumption 2021-2025 (MT)
Figure 123. Korea Opioids Value 2021-2025 ($ Millions)
Figure 124. Southeast Asia Opioids Consumption 2021-2025 (MT)
Figure 125. Southeast Asia Opioids Value 2021-2025 ($ Millions)
Figure 126. India Opioids Consumption 2021-2025 (MT)
Figure 127. India Opioids Value 2021-2025 ($ Millions)
Figure 128. Australia Opioids Consumption 2021-2025 (MT)
Figure 129. Australia Opioids Value 2021-2025 ($ Millions)
Figure 130. Germany Opioids Consumption 2021-2025 (MT)
Figure 131. Germany Opioids Value 2021-2025 ($ Millions)
Figure 132. France Opioids Consumption 2021-2025 (MT)
Figure 133. France Opioids Value 2021-2025 ($ Millions)
Figure 134. UK Opioids Consumption 2021-2025 (MT)
Figure 135. UK Opioids Value 2021-2025 ($ Millions)
Figure 136. Italy Opioids Consumption 2021-2025 (MT)
Figure 137. Italy Opioids Value 2021-2025 ($ Millions)
Figure 138. Russia Opioids Consumption 2021-2025 (MT)
Figure 139. Russia Opioids Value 2021-2025 ($ Millions)
Figure 140. Spain Opioids Consumption 2021-2025 (MT)
Figure 141. Spain Opioids Value 2021-2025 ($ Millions)
Figure 142. Egypt Opioids Consumption 2021-2025 (MT)
Figure 143. Egypt Opioids Value 2021-2025 ($ Millions)
Figure 144. South Africa Opioids Consumption 2021-2025 (MT)
Figure 145. South Africa Opioids Value 2021-2025 ($ Millions)
Figure 146. Israel Opioids Consumption 2021-2025 (MT)
Figure 147. Israel Opioids Value 2021-2025 ($ Millions)
Figure 148. Turkey Opioids Consumption 2021-2025 (MT)
Figure 149. Turkey Opioids Value 2021-2025 ($ Millions)
Figure 150. GCC Countries Opioids Consumption 2021-2025 (MT)
Figure 151. GCC Countries Opioids Value 2021-2025 ($ Millions)
Figure 152. Teva Opioids Market Share (2018-2020)
Figure 153. Mylan Opioids Market Share (2018-2020)
Figure 154. Purdue Pharma Opioids Market Share (2018-2020)
Figure 155. Amneal Pharma Opioids Market Share (2018-2020)
Figure 156. Collegium Opioids Market Share (2018-2020)
Figure 157. Mallinckrodt Opioids Market Share (2018-2020)
Figure 158. Pfizer Opioids Market Share (2018-2020)
Figure 159. J&J Opioids Market Share (2018-2020)
Figure 160. INSYS Opioids Market Share (2018-2020)
Figure 161. Endo Opioids Market Share (2018-2020)
Figure 162. Hikma Opioids Market Share (2018-2020)
Figure 163. Egalet Opioids Market Share (2018-2020)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs